| Literature DB >> 26711130 |
Kelly D Karpa1, Lindsay L Hom2, Paul Huffman3, Erik B Lehman4, Vernon M Chinchilli5, Paul Haidet6, Shou Ling Leong7.
Abstract
BACKGROUND: Adverse drug reactions are a leading cause of death in the United States. Safe and effective management of complex medication regimens is a skill for which recent medical school graduates may be unprepared when they transition to residency. We wished to assess the impact of a medication safety curriculum on student competency when evaluating medication therapeutic appropriateness as well as evaluate students' ability to transfer curricular material to management of patients in clinical settings.Entities:
Mesh:
Year: 2015 PMID: 26711130 PMCID: PMC4693404 DOI: 10.1186/s12909-015-0521-0
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Mnemonic for MR: “CALL DOCT IF”
| • Medications are the cause of patient’s current |
Demographics of students enrolled in the PCMH elective
| First year course was offered | Second year course was offered | Totals | |
|---|---|---|---|
| Total Students | 13 | 34 | 47 |
| Females | 7 | 22 | 29 |
| Males | 6 | 12 | 18 |
| 3rd Year Students | 3 | 28 | 31 |
| 4th Year Students | 10 | 6 | 16 |
|
| |||
| Family Medicine | 13 | 18 | 31 |
| Internal Medicine | 0 | 6 | 6 |
| Pediatrics | 0 | 2 | 2 |
| Surgery | 0 | 0 | |
| Med-Peds | 0 | 0 | 0 |
| Neurology | 0 | 4 | 4 |
| OB/GYN | 0 | 3 | 3 |
| Psychiatry | 0 | 1 | 1 |
|
| |||
| Family Medicine | 6 | 9 | 15 |
| Internal Medicine | 3 | 6 | 9 |
| Pediatrics | 0 | 4 | 4 |
| Surgery | 0 | 2 | 2 |
| Med-Peds | 1 | 1 | 2 |
| Neurology | 1 | 1 | 2 |
| OB/GYN | 0 | 6 | 6 |
| Psychiatry | 0 | 2 | 2 |
| Other Specialty | 0 | 2 | 2 |
aTwo students completed the course twice and one student took a medical leave of absence prior to commencement; therefore, there are three fewer students that matched to residencies compared to the overall number of students who were enrolled in the course
PCMH, Patient-Centered Medical Home; OB/GYN, obstetrics/gynecology; Med-Peds, medicine-pediatrics
Student reported abilities and confidence with reconciling and optimizing patients’ medications
| Categories | Time | Enrolled median (1st quartile, 3rd quartile) | Unadjusted P-value | Adjusted P-Value |
|---|---|---|---|---|
| Ability | ||||
| Able to identify drug-related adverse effects | Pre | 3 (2, 4) | 0.01 | NS |
| Post | 4 (3, 5) | |||
| Able to correct drug-related adverse effects | Pre | 2 (2, 4) | 0.006 | NS |
| Post | 3 (3, 4) | |||
| Able to identify therapeutic | Pre | 3.5 (2, 4) | 0.0002 | 0.005 |
| Post | 5 (4, 5) | |||
| Able to identify therapeutic omission | Pre | 2 (2, 4) | 0.002 | NS |
| Post | 4 (3, 5) | |||
| Able to evaluate medication appropriateness | Pre | 3 (2, 4) | <0.0001 | 0.0026 |
| Post | 4 (3, 5) | |||
| Able to develop medication monitoring plans | Pre | 3 (2, 3) | <0.0001 | 0.0026 |
| Post | 4 (3, 5) | |||
| Able to counsel patient on appropriate medication use | Pre | 3 (2, 4) | <0.0001 | 0.0026 |
| Post | 4 (4, 5) | |||
| Confidence/comfort level | ||||
| Confidence to accurately perform MR | Pre | 3 (2, 4) | 0.001 | 0.026 |
| Post | 4 (3, 4) | |||
| Confidence to accurately perform PTA | Pre | 2 (2, 3) | 0.006 | NS |
| Post | 3 (2, 4) | |||
| PTA is challenging | Pre | 5 (4, 5) | 0.02 | NS |
| Post | 4 (4, 5) | |||
| Overwhelmed by PTA | Pre | 4 (4, 5) | 0.09 | NS |
| Post | 4 (3, 5) |
Based on a 7-point Likert-type scale (0 to 6) with fixed terminal anchor responses
0 = less agreement with the statement
All values are represented as median (1st quartile, 3rd quartile). P-values represent comparison of enrolled student responses before and after the course
MR medication reconciliation, PTA pharmacotherapeutic assessments
Fig. 1n = 44 enrolled students that completed both the pre-course and post-course Medication Reconciliation (MR) Clinical Case assignment
Medication-related problems identified by students during the medication reconciliation patient project
| Type of medication problem | Number of patients impacted | Medications |
|---|---|---|
| Therapeutic Duplication | 6 | 2 proton pump inhibitors (2), 2 statins, 2 beta blockers (3) |
| Therapeutic Omission at Discharge | 8 | Clopidogrel, Ramipril, Ranitidine, Vitamin B12 injection, Budesonide, Lisinopril, Tums, Prenatal vitamins, Carvedilol |
| Patient Did Not Take Medications Listed in Electronic Health Record (Non-Adherence) | 11 | Lisinopril, Bupropion, Aspirin, Multivitamin, Pantoprazole (2), Omeprazole, Metformin, Levothyroxine, Ergocalciferol, Pravastatin, Furosemide, Bactrim, Antipsychotic |
| Medications Used by Patients but Not Listed in Electronic Health Record | 14 | Fiber, Bisacodyl, Pantoprazole, Pravastatin, Magnesium, Vitamin B, Ciprofloxacin, Reservatol, CoQ-10, Ramipril, Ondansetron, Tylenol, Vitamin B-12, Tramadol, Aspirin, Glyburide, Ventolin, Multivitamin, Dexamethasone |
| Discharge List Included a Drug that Should Have Been Discontinued | 1 | Griseofulvin |
| Dosage too High | 4 | Warfarin, Aspirin, Oxycodone, Clonidine |
| Dosage too Low | 9 | Furosemide, Omeprazole, Doxycycline, Levothyroxine, Insulin, Hydrochlorothiazide, Gabapentin, Glimepiride, Lisinopril, Welchol |
| Drug-Disease Interaction | 2 | Omeprazole, Diclofenac |
| Drug-Drug Interaction | 16 | Amlodipine-simvastatin (2) |
| Oxybutynin-potassium | ||
| Escitalopram-pantoprazole | ||
| Methotrexate-pantoprazole | ||
| Sulfamethoxazole/trimethoprim-methotrexate | ||
| Potassium-spironolactone | ||
| Hydrochlorothiazide-vitamin D | ||
| Hydrochlorothiazide -NSAIDs | ||
| Aspirin-furosemide | ||
| Fluconazole-citalopram | ||
| Risperdone-ropinerole | ||
| Warfarin (unspecified) | ||
| Currently Having an Adverse Drug Event | 16 | Omeprazole, Warfarin (3), Simvastatin, Metoprolol, Lasix, Amlodipine, Lisinopril, Insulin, Glimepiride, Antiretroviral, Clonidine, Tramadol, Tobramycin, Pravastatin, Hydrochlorothiazide, Medroxyprogesterone, Metformin, Risperidone |
| Lack of Indication for Medication | 6 | Omprepazole, Promethazine, Reservatol, Vitamin E, CoQ10, Wellbutrin, Cinnamon, Colchicine, Viagra |
| Previously documented allergy, intolerance, or side effect | 1 | Tenofovir |
| Taking brand when generic is available | 1 | Simvastatin |
Fig. 2n = 14 patients who completed both the medication knowledge questionnaire prior to MR with students and the follow-up questionnaire. Patient self-reported knowledge of medication side effects and interactions remained significant after Bonferroni correction